IL142216A0 - A polypeptide containing an immunogenic portion of a native wti and pharmaceutical compositions containing the same - Google Patents
A polypeptide containing an immunogenic portion of a native wti and pharmaceutical compositions containing the sameInfo
- Publication number
- IL142216A0 IL142216A0 IL14221699A IL14221699A IL142216A0 IL 142216 A0 IL142216 A0 IL 142216A0 IL 14221699 A IL14221699 A IL 14221699A IL 14221699 A IL14221699 A IL 14221699A IL 142216 A0 IL142216 A0 IL 142216A0
- Authority
- IL
- Israel
- Prior art keywords
- wti
- native
- pharmaceutical compositions
- same
- immunogenic portion
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464452—Transcription factors, e.g. SOX or c-MYC
- A61K39/464453—Wilms tumor 1 [WT1]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/164,223 US7063854B1 (en) | 1998-09-30 | 1998-09-30 | Composition and methods for WTI specific immunotherapy |
| US27648499A | 1999-03-25 | 1999-03-25 | |
| PCT/US1999/022819 WO2000018795A2 (en) | 1998-09-30 | 1999-09-30 | Compositions and methods for wt1 specific immunotherapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL142216A0 true IL142216A0 (en) | 2002-03-10 |
Family
ID=26860363
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14221699A IL142216A0 (en) | 1998-09-30 | 1999-09-30 | A polypeptide containing an immunogenic portion of a native wti and pharmaceutical compositions containing the same |
| IL142216A IL142216A (en) | 1998-09-30 | 2001-03-22 | Polypeptide containing an immunogenic portion of a native wti and pharmaceutical compositions containing the same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL142216A IL142216A (en) | 1998-09-30 | 2001-03-22 | Polypeptide containing an immunogenic portion of a native wti and pharmaceutical compositions containing the same |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1117687B1 (ko) |
| JP (3) | JP4243792B2 (ko) |
| KR (1) | KR100752065B1 (ko) |
| CN (1) | CN100486995C (ko) |
| AR (1) | AR021849A1 (ko) |
| AT (1) | ATE399179T1 (ko) |
| AU (1) | AU6407899A (ko) |
| BR (1) | BR9914116A (ko) |
| CA (1) | CA2349442C (ko) |
| CZ (1) | CZ20011144A3 (ko) |
| DE (1) | DE69938970D1 (ko) |
| ES (1) | ES2310052T3 (ko) |
| HK (1) | HK1039782B (ko) |
| HU (1) | HUP0103598A3 (ko) |
| IL (2) | IL142216A0 (ko) |
| MX (1) | MXPA01003344A (ko) |
| MY (1) | MY139226A (ko) |
| NO (1) | NO325839B1 (ko) |
| NZ (1) | NZ510600A (ko) |
| PL (1) | PL201881B1 (ko) |
| RU (1) | RU2237674C2 (ko) |
| SA (1) | SA00200872B1 (ko) |
| TR (1) | TR200101482T2 (ko) |
| TW (1) | TWI285648B (ko) |
| WO (1) | WO2000018795A2 (ko) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997026328A1 (en) | 1996-01-17 | 1997-07-24 | Imperial College Innovations Limited | Immunotherapy using cytotoxic t lymphocytes (ctl) |
| US7030212B1 (en) | 1998-07-31 | 2006-04-18 | Haruo Sugiyama | Tumor antigen based on products of the tumor suppressor gene WT1 |
| US7901693B2 (en) | 1998-09-30 | 2011-03-08 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| US7063854B1 (en) | 1998-09-30 | 2006-06-20 | Corixa Corporation | Composition and methods for WTI specific immunotherapy |
| US20030072767A1 (en) * | 1998-09-30 | 2003-04-17 | Alexander Gaiger | Compositions and methods for WT1 specific immunotherapy |
| US7115272B1 (en) | 1998-09-30 | 2006-10-03 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| US7144581B2 (en) | 2000-10-09 | 2006-12-05 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| US20030235557A1 (en) * | 1998-09-30 | 2003-12-25 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| US7329410B1 (en) | 1998-09-30 | 2008-02-12 | Corixa Corporation | Compositions and method for WT1 specific immunotherapy |
| US7655249B2 (en) | 1998-09-30 | 2010-02-02 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| GB9823897D0 (en) * | 1998-11-02 | 1998-12-30 | Imp College Innovations Ltd | Immunotherapeutic methods and molecules |
| AU7859900A (en) * | 1999-10-04 | 2001-05-10 | Corixa Corporation | Compositions and methods for wt1 specific immunotherapy |
| EP1261711A2 (en) * | 2000-02-22 | 2002-12-04 | Corixa Corporation | Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| JP3846199B2 (ja) | 2000-05-24 | 2006-11-15 | 治夫 杉山 | Ｗｔ１関連疾患の検査方法 |
| JP4592641B2 (ja) * | 2000-05-24 | 2010-12-01 | 治夫 杉山 | Ｗｔ１関連疾患の検査方法 |
| TWI318630B (en) * | 2001-03-22 | 2009-12-21 | Int Inst Cancer Immunology Inc | Wt1 modified peptide |
| DE60238958D1 (de) * | 2001-06-29 | 2011-02-24 | Chugai Pharmaceutical Co Ltd | Krebsimpfstoff mit einem Krebs-Antigen auf Grundlage des Produkts aus dem Tumorunterdrückungsgen WT1 und einem kationischen Liposom |
| US7553494B2 (en) | 2001-08-24 | 2009-06-30 | Corixa Corporation | WT1 fusion proteins |
| JP5230891B2 (ja) * | 2001-09-28 | 2013-07-10 | 株式会社癌免疫研究所 | 抗原特異的ｔ細胞の新規な誘導方法 |
| WO2003028758A1 (fr) * | 2001-09-28 | 2003-04-10 | Haruo Sugiyama | Nouvelle methode d'induction de lymphocytes t specifiques d'un antigene |
| CN101113163B (zh) | 2002-06-12 | 2010-10-06 | 株式会社国际癌症免疫研究所 | Hla-a24限制性癌抗原肽 |
| US7342092B2 (en) | 2002-09-12 | 2008-03-11 | International Institute Of Cancer Immunology, Inc. | Cancer antigen peptide formulations |
| JP4480580B2 (ja) | 2002-09-20 | 2010-06-16 | 株式会社癌免疫研究所 | Ｗｔ１置換型ペプチド |
| JP4498274B2 (ja) | 2003-01-15 | 2010-07-07 | 株式会社癌免疫研究所 | 二量体化ペプチド |
| US10500257B2 (en) | 2003-06-27 | 2019-12-10 | International Institute Of Cancer Immunology, Inc. | Method of selecting WT1 vaccine adaptive patient |
| KR101213015B1 (ko) * | 2003-11-05 | 2012-12-26 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | Ｗｔ１ 로부터 유도된 ｈｌａ-ｄｒ 결합성 항원 펩티드 |
| EP2186896B1 (en) | 2004-03-31 | 2015-11-04 | International Institute of Cancer Immunology, Inc. | Cancer antigen peptides derived from WT1 |
| EP1657250A1 (en) * | 2004-11-11 | 2006-05-17 | Charité - Universitätsmedizin Berlin | HLA-A *01-binding T-cell epitope of WT1 |
| ES2352855T3 (es) | 2005-11-30 | 2011-02-23 | International Institute Of Cancer Immunology, Inc. | Nuevos compuestos peptídicos del tumor de wilms. |
| US8759483B2 (en) | 2006-02-22 | 2014-06-24 | International Institute Of Cancer Immunology, Inc. | HLA-A* 3303-restricted WT1 peptide and pharmaceutical composition comprising the same |
| EP2687541A1 (en) * | 2006-10-17 | 2014-01-22 | Oncotherapy Science, Inc. | Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| NZ592510A (en) * | 2006-12-28 | 2012-11-30 | Int Inst Cancer Immunology Inc | HLA-A*1101-restricted WTI peptide and pharmaceutical composition comprising the same |
| NZ599161A (en) * | 2007-02-27 | 2012-07-27 | Int Inst Cancer Immunology Inc | Method for activation of helper t cell and composition for use in the method |
| EP2125868B1 (en) * | 2007-02-28 | 2015-06-10 | The Govt. Of U.S.A. As Represented By The Secretary Of The Department Of Health And Human Services | Brachyury polypeptides and methods for use |
| JP5808079B2 (ja) | 2007-03-05 | 2015-11-10 | 株式会社癌免疫研究所 | 癌抗原特異的ｔ細胞のレセプター遺伝子およびそれによりコードされるペプチドならびにそれらの使用 |
| WO2009066462A1 (ja) * | 2007-11-20 | 2009-05-28 | Nec Corporation | 細胞傷害性ｔ細胞の誘導方法、細胞傷害性ｔ細胞の誘導剤、およびそれを用いた医薬組成物およびワクチン |
| EP2228072B1 (en) * | 2007-12-05 | 2018-06-13 | International Institute of Cancer Immunology, Inc. | Cancer vaccine composition |
| AR076349A1 (es) | 2009-04-23 | 2011-06-01 | Int Inst Cancer Immunology Inc | Peptido auxiliar del antigeno del cancer |
| EP2432893B1 (en) * | 2009-05-19 | 2019-05-01 | University Of Miami | Compositions, kits and methods for in vitro antigen presentation, assessing vaccine efficacy, and assessing immunotoxicity of biologics and drugs |
| KR20140009168A (ko) | 2010-10-05 | 2014-01-22 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | 헬퍼 ｔ 세포의 활성화 방법 |
| EA201391449A1 (ru) * | 2011-04-01 | 2014-03-31 | Мемориал Слоан-Кеттеринг Кэнсер Сентер | Антитела против пептидов цитозоля |
| EP3447140A3 (en) | 2011-06-28 | 2019-05-29 | International Institute of Cancer Immunology, Inc. | Receptor gene for peptide cancer antigen-specific t cell |
| WO2014007266A1 (ja) | 2012-07-02 | 2014-01-09 | 大日本住友製薬株式会社 | 癌抗原ペプチド経皮剤 |
| CN104995203B (zh) | 2012-12-17 | 2019-06-28 | 大塚制药株式会社 | 辅助性t细胞的活化方法 |
| WO2014142102A1 (ja) | 2013-03-12 | 2014-09-18 | 大日本住友製薬株式会社 | 液体水性組成物 |
| US10588952B2 (en) | 2013-03-29 | 2020-03-17 | Sumitomo Dainippon Pharma Co., Ltd. | Conjugate vaccine using trimming function of ERAP1 |
| EP3461493A1 (en) | 2013-03-29 | 2019-04-03 | Sumitomo Dainippon Pharma Co., Ltd. | Wt1 antigen peptide conjugate vaccine |
| CN105378479A (zh) * | 2013-05-13 | 2016-03-02 | 株式会社癌免疫研究所 | 用于预测免疫疗法的临床效果的方法 |
| CN106170297A (zh) * | 2013-09-20 | 2016-11-30 | 纪念斯隆-凯特琳癌症中心 | 用于wt‑1‑阳性疾病的组合/辅助疗法 |
| KR101804343B1 (ko) | 2014-02-26 | 2017-12-04 | 텔라 가부시키가이샤 | Ｗｔ１ 항원성 폴리펩티드 및 상기 폴리펩티드를 포함하는 항종양제 |
| KR20170092660A (ko) * | 2014-12-11 | 2017-08-11 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | 혈관 신생병의 면역 요법 |
| US20190381098A1 (en) * | 2015-09-10 | 2019-12-19 | Memorial Sloan Kettering Cancer Center | Methods of treating multiple myeloma and plasma cell leukemia by t cell therapy |
| LT3377516T (lt) * | 2015-11-20 | 2022-09-26 | Memorial Sloan Kettering Cancer Center | Kompozicija vėžiui gydyti |
| CN105254760B (zh) * | 2015-11-21 | 2018-08-17 | 福州迈新生物技术开发有限公司 | 一株分泌抗wt1蛋白的单克隆抗体及其应用 |
| EP3549957A4 (en) | 2016-11-30 | 2020-08-05 | Sumitomo Dainippon Pharma Co., Ltd. | WT1-HELPER PEPTIDE AND COMBINATION OF THE SAYING PEPTIDE AND A CANCER ANTIGEN PEPTIDE CONJUGATE |
| EP3604325A4 (en) | 2017-03-30 | 2021-01-13 | Sumitomo Dainippon Pharma Co., Ltd. | WT1 CANCER ANTIGEN PEPTIDE AND PEPTIDE CONJUGATE BODY WITH IT |
| SG11201909153UA (en) * | 2017-04-10 | 2019-10-30 | Immatics Biotechnologies Gmbh | Peptides and combination thereof for use in the immunotherapy against cancers |
| SG11202005632SA (en) | 2017-12-21 | 2020-07-29 | Hoffmann La Roche | Antibodies binding to hla-a2/wt1 |
| CN109758575B (zh) * | 2018-02-14 | 2022-08-30 | 上海微球生物科技有限公司 | 充分多样的双亲性mhc ii结合多肽、免疫载体微球及其制备方法和应用 |
| CN113382746A (zh) | 2018-09-28 | 2021-09-10 | 大日本住友制药株式会社 | 注射用组合物 |
| TW202045528A (zh) | 2019-02-28 | 2020-12-16 | 日商大日本住友製藥股份有限公司 | 選擇可期待用於治療或預防癌之醫藥組合物之效果之對象之方法 |
| KR20230009872A (ko) * | 2020-05-12 | 2023-01-17 | 큐 바이오파마, 인크. | 다량체 t-세포 조절 폴리펩타이드 및 이의 사용 방법 |
| CA3182959A1 (en) | 2020-05-12 | 2021-11-18 | Sumitomo Pharma Co., Ltd. | Pharmaceutical composition for treating cancer |
| CN111647066B (zh) * | 2020-07-01 | 2020-12-18 | 维肽瀛(上海)生物技术有限公司 | Wt1多肽肿瘤抑制剂 |
| KR102476515B1 (ko) * | 2020-09-11 | 2022-12-12 | 한국생명공학연구원 | 치주 질환 특이 항체 및 이의 용도 |
| KR20220034563A (ko) * | 2020-09-11 | 2022-03-18 | 한국생명공학연구원 | 신규 치주 질환 특이 항체 및 이의 용도 |
| AU2022327884A1 (en) | 2021-08-12 | 2024-02-22 | International Institute Of Cancer Immunology, Inc. | Pharmaceutical composition and method for treatment or prevention of cancer |
| EP4410304A1 (en) * | 2021-09-24 | 2024-08-07 | Cha Vaccine Research Institute Co., Ltd | Anti-cancer vaccine composition comprising peptides derived from tumor-associated antigen, and adjuvant consisting of lipopeptide and immunoactive substance, and use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991007509A1 (en) * | 1989-11-13 | 1991-05-30 | Massachusetts Institute Of Technology | Localization and characterization of the wilms's tumor gene |
| US5705159A (en) * | 1993-08-31 | 1998-01-06 | John Wayne Cancer Institute | Immunoreactive peptide sequence from a 43 KD human cancer antigen |
| US5622835A (en) * | 1994-04-28 | 1997-04-22 | The Wistar Institute Of Anatomy & Biology | WT1 monoclonal antibodies |
| AU3896899A (en) * | 1998-05-11 | 1999-11-29 | Salk Institute For Biological Studies, The | Compositions for the treatment of tumors, and uses thereof |
| US7030212B1 (en) * | 1998-07-31 | 2006-04-18 | Haruo Sugiyama | Tumor antigen based on products of the tumor suppressor gene WT1 |
-
1999
- 1999-09-30 AT AT99951690T patent/ATE399179T1/de not_active IP Right Cessation
- 1999-09-30 MX MXPA01003344A patent/MXPA01003344A/es not_active IP Right Cessation
- 1999-09-30 NZ NZ510600A patent/NZ510600A/en not_active IP Right Cessation
- 1999-09-30 PL PL348595A patent/PL201881B1/pl not_active IP Right Cessation
- 1999-09-30 BR BR9914116-7A patent/BR9914116A/pt not_active Application Discontinuation
- 1999-09-30 CZ CZ20011144A patent/CZ20011144A3/cs unknown
- 1999-09-30 AU AU64078/99A patent/AU6407899A/en not_active Abandoned
- 1999-09-30 WO PCT/US1999/022819 patent/WO2000018795A2/en active Application Filing
- 1999-09-30 CN CNB998133493A patent/CN100486995C/zh not_active Expired - Fee Related
- 1999-09-30 MY MYPI99004243A patent/MY139226A/en unknown
- 1999-09-30 CA CA2349442A patent/CA2349442C/en not_active Expired - Fee Related
- 1999-09-30 RU RU2001111834A patent/RU2237674C2/ru not_active IP Right Cessation
- 1999-09-30 ES ES99951690T patent/ES2310052T3/es not_active Expired - Lifetime
- 1999-09-30 TR TR2001/01482T patent/TR200101482T2/xx unknown
- 1999-09-30 AR ARP990104969A patent/AR021849A1/es active IP Right Grant
- 1999-09-30 IL IL14221699A patent/IL142216A0/xx unknown
- 1999-09-30 DE DE69938970T patent/DE69938970D1/de not_active Expired - Lifetime
- 1999-09-30 HU HU0103598A patent/HUP0103598A3/hu unknown
- 1999-09-30 JP JP2000572253A patent/JP4243792B2/ja not_active Expired - Fee Related
- 1999-09-30 KR KR1020017004049A patent/KR100752065B1/ko not_active IP Right Cessation
- 1999-09-30 EP EP99951690A patent/EP1117687B1/en not_active Expired - Lifetime
- 1999-12-22 TW TW094123744A patent/TWI285648B/zh active
-
2000
- 2000-01-22 SA SA00200872A patent/SA00200872B1/ar unknown
-
2001
- 2001-03-22 IL IL142216A patent/IL142216A/en not_active IP Right Cessation
- 2001-03-29 NO NO20011613A patent/NO325839B1/no not_active IP Right Cessation
-
2002
- 2002-01-24 HK HK02100544.9A patent/HK1039782B/zh unknown
-
2006
- 2006-08-23 JP JP2006227215A patent/JP2007001984A/ja active Pending
-
2007
- 2007-10-26 JP JP2007279673A patent/JP4235984B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL142216A0 (en) | A polypeptide containing an immunogenic portion of a native wti and pharmaceutical compositions containing the same | |
| IL145620A0 (en) | A polypeptide containing an immunogenic portion of a breast tumor protein and pharmaceutical compositions containing the same | |
| IL149754A0 (en) | Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same | |
| EP0950665A4 (en) | PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM | |
| IL137904A0 (en) | Peptide analogues of insulin and pharmaceutical compositions containing the same | |
| IL137417A0 (en) | Polypeptides containing at least a portion of a lung tumor protien and pharmaceutical compositions containing the same | |
| HUP0003761A2 (en) | Substituted alkanohydroxamic acids and pharmaceutical compositions containing them | |
| IL143633A0 (en) | Peptides containing ovarian carcinoma proteins and pharmaceutical compositions and vaccines containing the same | |
| IL191904A0 (en) | Pharmaceutical and compositions containing a?? fragments | |
| AP9901702A0 (en) | LH-RH peptide analogues their uses and pharmaceutical compositions containing them | |
| IL131319A0 (en) | 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same | |
| IL135646A0 (en) | α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| HUP0001309A3 (en) | 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them | |
| HU9800147D0 (en) | Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them | |
| ZA983849B (en) | Pharmaceutical compositions of tizoxanide and nitazoxanide. | |
| IL145733A0 (en) | A polpyeptide containing an immunogenic portion of a breast protein and pharmaceutical compositions containing the same | |
| HUP0100102A3 (en) | Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same | |
| IL125908A (en) | Peptides and pharmaceutical compositions comprising same | |
| HUP0003330A3 (en) | Pharmaceutical compositions containing tizoxanide and nitazoxanide | |
| IL126734A0 (en) | Cosmetic and/or pharmaceutical and/or dermatological compositions | |
| IL136045A0 (en) | Pyridylpyrrole derivatives and pharmaceutical compositions containing the same | |
| IL125262A0 (en) | Synthetic peptides and pharmaceutical compositions comprising them | |
| ZA9811105B (en) | Cosmetic and pharmaceutical composition | |
| IL152221A0 (en) | A polypeptide containing an immunogenic portion of breast tumor protein and pharmaceutical compositions containing the same | |
| HUP0004274A3 (en) | Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof |